FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

425646006: Tetracosactide acetate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2674735011 Cosyntropin acetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2674736012 Tetracosactide acetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3484967018 Tetracosactide acetate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
844891000172114 acétate de tétracosactide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tetracosactide acetate Is a Tetracosactide false Inferred relationship Some
Tetracosactide acetate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Anterior pituitary hormone (disposition) true Inferred relationship Some
Tetracosactide acetate Is a Corticotropic agent false Inferred relationship Some
Tetracosactide acetate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Tetracosactide true Inferred relationship Some
Tetracosactide acetate Is a Synthetic hormone agent false Inferred relationship Some
Tetracosactide acetate Is a Adrenocorticotropic hormone false Inferred relationship Some
Tetracosactide acetate Is a Adrenocorticotropic hormone and/or adrenocorticotropic hormone derivative true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely tetracosactide acetate 250 microgram/1 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Tetracosactide acetate Inferred relationship Some 1
Product containing precisely tetracosactide acetate 250 microgram/1 milliliter conventional release solution for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Tetracosactide acetate Inferred relationship Some 1
Product containing precisely tetracosactide acetate 250 microgram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tetracosactide acetate Inferred relationship Some 1
Product containing precisely tetracosactide acetate 250 microgram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tetracosactide acetate Inferred relationship Some 1
Tetracosactide (as tetracosactide acetate) 250 microgram/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tetracosactide acetate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start